Brief: Replicel life sciences says non-brokered private placement of up to 8 mln units
14/09/2016 20:42
Sept 14 (Reuters) - Replicel Life Sciences:
* Replicel Life Sciences announces non-brokered private
placement
* Intends to undertake non-brokered private placement
financing of up to 8 million units at price of $0.52 per unit
* Proceeds from offering will be primarily used for clinical
trials research and development device manufacturing and testing
Source text for Eikon: ID:nCCN3yfhD6
Further company coverage: RP.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Replicel Life Sciences
See all newsBrief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector